Irazu Oncology

Developer of vaccines for colorectal cancer patients

placeBaltimore, Maryland, United States calendar_todayFounded 2022 groups2 employees language irazuoncology.com

Innovation

1 patent family — focus: Human necessities; filing pace active. Cited 1 times.

YearFilings
20241
20251

Investor mix

4 investors on record; lead investors include Wexford Science & Technology, Abell Foundation.

Investor typeCountShare
Venture capital125%
Other / undisclosed375%
Coming soon